EktaH’s lead compound NKS-3 shows 50% reduction in post-GLP-1 weight rebound with novel obesity treatment & reports positive phase I data

Join Pharma | Login

	Editorial


	STRIP CUTTING OF MEDICINES
	Wednesday, May 13, 2026
	The All India Organisation of Chemists and Druggists (AIOCD) has expressed concern over the Drugs Consultative Committee’s recent recommendation on dispensing of exact prescription quantities of
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	EktaH’s lead compound NKS-3 shows 50% reduction in post-GLP-1 weight rebound with novel obesity treatment & reports positive phase I data
17:40 [IST]	Karnataka FDA sets benchmark in drug safety with rapid recall portal for NSQ and NPDS medicines
17:30 [IST]	Roche Pharma India launches subcutaneous immunotherapy for lung cancer, Tecentriq SC
17:20 [IST]	Pharma Quality Excellence Awards focus on building robust quality practices
17:00 [IST]	Infex Therapeutics secures £4.3 million funding to advance anti-infective pipeline targeting drug-resistant infections
16:00 [IST]	Labcorp and Epic expand collaboration to advance diagnostic integration across hospitals and health systems

more news >>

TOP NEWS


08:00 [IST]	Amendment in Recruitment Rules for DCGI not aligned with Rule 49A of D&C Rules: Experts
08:00 [IST]	Panel recommends CDSCO to develop uniform mechanism to handle misleading ads of Ayush products
08:00 [IST]	KSRPA alerts Karnataka govt on noncompliance of Rule 64 & 65 of Drugs and Cosmetic Act
08:00 [IST]	Indian regulators tighten drug quality oversight as substandard and spurious medicine cases rise in five years
08:00 [IST]	JAKs clock in sales of Rs. 1,600 crore in first nine months of FY26
08:00 [IST]	India’s healthcare problem is not shortage, it is distance: Dr Harilal Bhaskar

more news >>

YESTERDAY'S NEWS


17:30 [IST]	JDMEHF to hold healthcare & education outreach initiatives
17:20 [IST]	WFNS Innovation & Technology Committee with Time Medical, strengthens neurosurgical innovation
16:45 [IST]	Agilent and Veeda Lifesciences unveil joint analytical Centre of Excellence to accelerate GLP-1 and complex biologics development services
16:30 [IST]	AstraZeneca launches K+ Connect to advance hyperkalaemia management in heart failure and CKD across India
15:45 [IST]	Lilly launches Lormalzi, first and only once-monthly amyloid plaque-targeting therapy to treat early symptomatic Alzheimer’s disease in India
14:50 [IST]	Abbott introduces Ensure Strength Pro in India to support healthy ageing

more news >>

INTERVIEW


Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training
Lalit Kumar Goel, State Drug Controller (SDC) of Haryana

Past Interviews...

	What's New?

Dr Reddy’s Q4 revenues down by 11.6% at Rs. 7,516 crore, PAT plummeted to 86.2% at Rs. 220 crore Biocon net profit declines 63.4% in Q4 FY26 Indoco Remedies net loss narrows during Q4, FY26 Emcure Pharma net profit up 23.6% in Q4 FY26 Syngene PAT before exceptional items slips in Q3 by 16%, revenue up 2% to Rs. 1,037 crore

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers